Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Goepfert

Showing results (201-210 of 250) with videos related to

Pageof 25
Sort By:
The Journal of Clinical Endocrinology and Metabolism|September 1, 1992
The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patientsN A Samaan, P N Schultz, R C Hickey, et al.
British Journal of Cancer|July 29, 1999
PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinomaC Simon, M J Hicks, A J Nemechek, et al.
Journal of the National Cancer Institute|June 1, 1994
13-Cis-retinoic acid plus interferon-alpha 2a in recurrent respiratory papillomatosisS M Lippman, D T Donovan, R A Frankenthaler, et al.
The Laryngoscope|March 1, 1988
Interferon alfa-n1 (Wellferon) in juvenile onset recurrent respiratory papillomatosis: results of a randomized study in twelve collaborative institutionsH Kashima, B Leventhal, K Clark, et al.
Cancer Treatment Reports|February 1, 1984
Phase II study of PCNU in the treatment of head and neck carcinomaI W Dimery, S S Legha, W K Murphy, et al.
Cancer Research|April 1, 1993
Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tractK Y Chung, T Mukhopadhyay, J Kim, et al.
International Journal of Cancer|June 22, 1995
Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinomaA K el-Naggar, S Lai, M A Luna, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 1989
Hyperfractionated radiotherapy in the treatment of squamous cell carcinomas of the supraglottic larynxC D Wendt, L J Peters, K K Ang, et al.
Archives of Otolaryngology--Head & Neck Surgery|November 1, 1992
Ampicillin-sulbactam vs clindamycin in head and neck oncologic surgery. The need for gram-negative coverageR S Weber, I Raad, R Frankenthaler, et al.
The Laryngoscope|May 20, 1998
Radiation therapy for early stage (T1-T2) sarcomatoid carcinoma of true vocal cords: outcomes and patterns of failureM T Ballo, A S Garden, A K El-Naggar, et al.
Pageof 25

Showing results (201-210 of 250) with videos related to

Sort By:
Pageof 25
The Journal of Clinical Endocrinology and Metabolism|September 1, 1992
The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patientsN A Samaan, P N Schultz, R C Hickey, et al.
British Journal of Cancer|July 29, 1999
PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinomaC Simon, M J Hicks, A J Nemechek, et al.
Journal of the National Cancer Institute|June 1, 1994
13-Cis-retinoic acid plus interferon-alpha 2a in recurrent respiratory papillomatosisS M Lippman, D T Donovan, R A Frankenthaler, et al.
The Laryngoscope|March 1, 1988
Interferon alfa-n1 (Wellferon) in juvenile onset recurrent respiratory papillomatosis: results of a randomized study in twelve collaborative institutionsH Kashima, B Leventhal, K Clark, et al.
Cancer Treatment Reports|February 1, 1984
Phase II study of PCNU in the treatment of head and neck carcinomaI W Dimery, S S Legha, W K Murphy, et al.
Cancer Research|April 1, 1993
Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tractK Y Chung, T Mukhopadhyay, J Kim, et al.
International Journal of Cancer|June 22, 1995
Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinomaA K el-Naggar, S Lai, M A Luna, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 1989
Hyperfractionated radiotherapy in the treatment of squamous cell carcinomas of the supraglottic larynxC D Wendt, L J Peters, K K Ang, et al.
Archives of Otolaryngology--Head & Neck Surgery|November 1, 1992
Ampicillin-sulbactam vs clindamycin in head and neck oncologic surgery. The need for gram-negative coverageR S Weber, I Raad, R Frankenthaler, et al.
The Laryngoscope|May 20, 1998
Radiation therapy for early stage (T1-T2) sarcomatoid carcinoma of true vocal cords: outcomes and patterns of failureM T Ballo, A S Garden, A K El-Naggar, et al.
Pageof 25